Is Repare Therapeutics Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: RPTX) stock is to Buy RPTX stock.
Out of 3 analysts, 1 (33.33%) are recommending RPTX as a Strong Buy, 1 (33.33%) are recommending RPTX as a Buy, 1 (33.33%) are recommending RPTX as a Hold, 0 (0%) are recommending RPTX as a Sell, and 0 (0%) are recommending RPTX as a Strong Sell.
What is RPTX's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: RPTX) forecast ROE is N/A, which is considered weak.
What is RPTX's Price Target?
According to 3 Wall Street analysts that have issued a 1 year RPTX price target, the average RPTX price target is $18.67, with the highest RPTX stock price forecast at $26.00 and the lowest RPTX stock price forecast at $14.00.
On average, Wall Street analysts predict that Repare Therapeutics's share price could reach $18.67 by Jun 9, 2024. The average Repare Therapeutics stock price prediction forecasts a potential upside of 55.3% from the current RPTX share price of $12.02.
What is RPTX's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: RPTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.09%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.